The cost-effectiveness of HIV prevention interventions for HIV-infected patients seen in clinical settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 3, 2011, Pages

  Marseille, Elliot ^a   Shade, Starley B ^b   Myers, Janet ^b   Morin, Steve ^b  

^a Health Strategies International   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cost effectiveness; HIV; prevention

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ASSESSMENT; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTERVENTION STUDY; MEDICAL SPECIALIST; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

COST-BENEFIT ANALYSIS; COUNSELING; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HUMANS; INFECTION CONTROL; MALE; UNITED STATES;

EID: 79951807789     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318204123e     Document Type: Article

References (13)

1. Fisher JD, Fisher WA, Cornman DH, et al. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006,41:44-52. (Pubitemid 41786018)
2. Gardner LI, Marks G, O'Daniels CM, et al. Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV. AIDS Patient Care STDs. 2008,22:627-635.
3. Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multiclinic assessment. AIDS. 2004,18:1179-1186. (Pubitemid 38738517)
4. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998,339:1897-1904. (Pubitemid 29013934)
5. Myers JJ, Shade SB, Rose CD, et al. Interventions Delivered in Clinical Settings are Effective in Reducing Risk of HIV Transmission Among People LivingWith HIV: Results From the Health Resources and Services Administration (HRSA)'s Special Projects of National Significance Initiative. 2010.
6. Koester KA, Maiorana A, Vernon K, et al. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: challenges and lessons learned. AIDS Behav. 2007,11:S17-S29. (Pubitemid 47319536)
7. Gold M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
8. Muenning P. Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care. San Francisco: Jossey-Bass; 2002.
9. Morin SF, Myers JJ, Shade SB, et al. Predicting HIV transmission risk among HIV-infected patients seen in clinical settings. AIDS Behav. 2007,11:S6-S16. (Pubitemid 47319538)
10. Schackman BR, Gebo KA, Walensky RP, et al. The Lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006,44:990-997. (Pubitemid 44674030)
11. Morgan MG, Henrion M. Uncertainty: A Guide to Dealing With Uncertainty in Quantitative Risk and Policy Analysis. Cambridge: Cambridge University Press; 1990.
12. Cohen DA, Wu SY, Farley TA. Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr. 2004,37: 1404-1414. (Pubitemid 39435055)
13. Lau JT, Tsui HY, Wang QS. Effects of two telephone survey methods on the level of reported risk behaviours. Sex Transm Infect. 2003,79:325-331. (Pubitemid 37026354)